Genetic susceptibility of the ANRIL locus has been associated with CAD [96,97], but also with atherosclerosis [98], intracranial aneurysms [99], and type 2 diabetes [100]. This evidence concerns the gene CDKN2B-AS1 and coronary artery disorder.